(Q45038131)

8 December 2017

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans (English)

1 reference

8 December 2017

0 references

1 reference

1 reference

1

1 reference

8 December 2017

2

Hans-Ulrich Häring

1 reference

PubMed ID

23558619

8 December 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

8 December 2017

1 reference

8 December 2017

19

1 reference

8 December 2017

4

1 reference

8 December 2017

394-395

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.3116

8 December 2017

0 references

cites work

Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.

1 reference

12 December 2020

Plasma fetuin-A levels and the risk of type 2 diabetes

1 reference

12 December 2020

Fetuin-A: the missing link in lipid-induced inflammation

1 reference

12 December 2020

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

1 reference

12 December 2020

The metabolically benign and malignant fatty liver

1 reference

12 December 2020

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

1 reference

12 December 2020

Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke

1 reference

12 December 2020

Fetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cells

1 reference

12 December 2020

Fetuin-A induces cytokine expression and suppresses adiponectin production

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.3116

1 reference

PubMed ID

23558619

Dimensions Publication ID

8 December 2017

0 references

1 reference

PubMed ID

23558619